Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+65.3%
5Y CAGR+70.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+65.3%/yr
vs +144.5%/yr prior
5Y CAGR
+70.2%/yr
Recent deceleration
Acceleration
-79.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
14.3x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.27M | +19.5% |
| 2024 | $2.74M | +267.3% |
| 2023 | $746000.00 | +2.9% |
| 2022 | $725000.00 | +53.6% |
| 2021 | $472000.00 | +106.1% |
| 2020 | $229000.00 | -11.0% |
| 2019 | $257199.00 | +1167.4% |
| 2018 | $20294.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |